- Home
- NEO vs UVV Comparison
NEO vs UVV Comparison
Compare NEO & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- UVV
- Stock Information
- Founded
- NEO 2001
- UVV 1886
- Country
- NEO United States
- UVV United States
- Employees
- NEO N/A
- UVV N/A
- Industry
- NEO Precision Instruments
- UVV Farming/Seeds/Milling
- Sector
- NEO Health Care
- UVV Industrials
- Exchange
- NEO Nasdaq
- UVV Nasdaq
- Market Cap
- NEO 1.2B
- UVV 1.3B
- IPO Year
- NEO 1999
- UVV N/A
- Fundamental
- Price
- NEO $9.62
- UVV $56.11
- Analyst Decision
- NEO Strong Buy
- UVV
- Analyst Count
- NEO 10
- UVV 0
- Target Price
- NEO $19.78
- UVV N/A
- AVG Volume (30 Days)
- NEO 1.5M
- UVV 153.9K
- Earning Date
- NEO 04-29-2025
- UVV 05-21-2025
- Dividend Yield
- NEO N/A
- UVV 5.78%
- EPS Growth
- NEO N/A
- UVV 5.05
- EPS
- NEO N/A
- UVV 4.86
- Revenue
- NEO $660,566,000.00
- UVV $2,827,901,000.00
- Revenue This Year
- NEO $12.89
- UVV N/A
- Revenue Next Year
- NEO $11.36
- UVV N/A
- P/E Ratio
- NEO N/A
- UVV $11.61
- Revenue Growth
- NEO 11.65
- UVV 6.40
- 52 Week Low
- NEO $8.98
- UVV $45.19
- 52 Week High
- NEO $19.11
- UVV $59.13
- Technical
- Relative Strength Index (RSI)
- NEO 41.15
- UVV 60.63
- Support Level
- NEO $9.57
- UVV $53.55
- Resistance Level
- NEO $10.37
- UVV $57.08
- Average True Range (ATR)
- NEO 0.65
- UVV 1.18
- MACD
- NEO 0.13
- UVV 0.07
- Stochastic Oscillator
- NEO 31.79
- UVV 76.17
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About UVV Universal Corporation
Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.